Suppr超能文献

[姑息治疗患者的呼吸困难——隐匿性症状]

[Dyspnea in patients in palliative situations - the invisible symptom].

作者信息

Eckstein Sandra

机构信息

Abteilung für Palliative Care, Universitätsspital Basel,

出版信息

Ther Umsch. 2024 Aug;81(4):145-150. doi: 10.23785/TU.2024.04.008.

Abstract

Dyspnea is a common and distressing symptom in patients with advanced malignant and non-malignant diseases. It is a subjective experience that can only be described by the patients themselves and can be associated with a massive reduction in quality of life, including social isolation and wish to hasten death. Often there is an affective component such as anxiety or panic. Objective parameters do not necessarily correlate with the subjective experience. Health professionals often underestimate and inadequately treat the burden of dyspnea. The introduction of the concept of chronic breathlessness syndrome or acute-on-chronic-breathlessness aims to illustrate the nature of the condition and facilitate the identification and access to appropriate treatment. The management of dyspnea is complex, and for effective treatment, a combination of general, non-pharmacological, and pharmacological measures is usually advisable. Opioids should be offered to patients with incurable cancer and refractory dyspnea for symptom relief. They can be supplemented with benzodiazepines in cases of concomitant anxiety. The administration of oxygen is only indicated in cases of hypoxemia. Key measures include education, self-management skills acquisition and advance care planning for emergency situations.

摘要

呼吸困难是晚期恶性和非恶性疾病患者常见且令人痛苦的症状。它是一种主观体验,只能由患者自己描述,并且可能与生活质量大幅下降相关,包括社交孤立和希望加速死亡。通常存在焦虑或恐慌等情感成分。客观参数不一定与主观体验相关。卫生专业人员常常低估并未能充分治疗呼吸困难的负担。引入慢性呼吸急促综合征或急性加重慢性呼吸急促的概念旨在阐明该病症的本质,并促进对适当治疗方法的识别和获取。呼吸困难的管理很复杂,为了进行有效治疗,通常建议综合采用一般措施、非药物措施和药物措施。对于患有无法治愈的癌症且呼吸困难难治的患者,应使用阿片类药物缓解症状。如果伴有焦虑,可辅以苯二氮䓬类药物。仅在低氧血症的情况下才给予氧气。关键措施包括教育、获取自我管理技能以及针对紧急情况的预先护理计划。

相似文献

1
[Dyspnea in patients in palliative situations - the invisible symptom].
Ther Umsch. 2024 Aug;81(4):145-150. doi: 10.23785/TU.2024.04.008.
2
Management of Breathlessness in Patients With Advanced Cancer: A Narrative Review.
Am J Hosp Palliat Care. 2016 Apr;33(3):286-90. doi: 10.1177/1049909114554796. Epub 2014 Oct 15.
3
Managing dyspnea and cough.
Hematol Oncol Clin North Am. 2002 Jun;16(3):557-77, viii. doi: 10.1016/s0889-8588(02)00019-9.
4
The palliation of dyspnea in terminal disease.
Am J Hosp Palliat Care. 1998 Nov-Dec;15(6):322-30. doi: 10.1177/104990919801500606.
5
[Management of refractory breathlessness in patients with advanced disease].
Internist (Berl). 2016 Oct;57(10):978-982. doi: 10.1007/s00108-016-0122-y.
6
Management of refractory breathlessness in patients with advanced cancer.
Wien Med Wochenschr. 2009 Dec;159(23-24):591-8. doi: 10.1007/s10354-009-0728-y.
7
Opioids, respiratory function, and dyspnea.
Am J Hosp Palliat Care. 2003 Jan-Feb;20(1):57-61. doi: 10.1177/104990910302000113.
8
[Dyspnea in cancer: causes and symptomatic treatment].
Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2421-4.
9
Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD011008. doi: 10.1002/14651858.CD011008.pub2.
10
Symptom control and palliative care: management of breathlessness.
Br J Hosp Med (Lond). 2009 Apr;70(4):212-6. doi: 10.12968/hmed.2009.70.4.41624.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验